| Tara Michelle Miller, NP | |
|
500 Osborn Blvd, Sault Sainte Marie, MI 49783-1822 | |
| (906) 636-4460 | |
| Not Available |
| Full Name | Tara Michelle Miller |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 500 Osborn Blvd, Sault Sainte Marie, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043088826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4704223862 (Michigan) | Secondary |
| 363L00000X | Nurse Practitioner | 4704223862 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tara Michelle Miller, NP 500 Osborn Blvd, Sault Sainte Marie, MI 49783-1822 Ph: (906) 635-4518 | Tara Michelle Miller, NP 500 Osborn Blvd, Sault Sainte Marie, MI 49783-1822 Ph: (906) 636-4460 |
News Archive
Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727.
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
This year's intersection of the deadlines to sign up for health insurance, as well as to file taxes, elevated the role of many tax preparers who have been educating uninsured clients about the health law. Some tax preparers contend the two deadlines should be permanently connected.
Two-thirds of small medical device and diagnostic companies-the drivers of innovation in the sector-are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industrywide survey about FDA's 510(k) product review process by researchers at Northwestern University.
› Verified 8 days ago